643. Infectious Complications of Intravenous Drug Use: A Single-Center Review of Hospitalized Patients in Massachusetts, 2012-2015
Session: Poster Abstract Session: Outbreaks and Public Health Across the Globe
Thursday, October 5, 2017
Room: Poster Hall CD
Background:

The national opioid epidemic has been accompanied by precipitous increases in overdose deaths and hospitalizations for infectious complications of injection drug use (IDU). Despite this, there is scant literature addressing the topic. We aimed to describe demographic characteristics, type of infection, healthcare utilization, disposition and outcomes among patients hospitalized for IDU-related infection over a multi-year period at a large tertiary care referral center in Boston, MA.

Methods:

We conducted a retrospective chart review of patients hospitalized for IDU-related infection from 1/1/2012-9/30/2015. 901 charts were initially identified using administrative codes; 234 met the following inclusion criteria: 1) hospitalization within the study period for treatment of ≥1 of 6 selected infections and 2) IDU within 6-months preceding qualifying hospitalization. During the study period, 234 patients had 488 cumulative admissions. Admissions for IDU-related infection and ≤30-day readmission, all-cause, underwent detailed abstraction (N=338; 69%).

Results:

Of 234 patients, over half were male (57%; N=134), 78% white (N=183), 17% homeless (N=37), 88% had public insurance (N=210); 53% had a history of Hepatitis C infection (N=124), most with untreated or unknown infection status (86%; N=107). Average age was 38 (range 18-75). Fifty-eight percent (N=136) of patients had one admission during the study period, the remainder had between 2-13 (mean = 3.6). Sentinel admission infection types were 1) skin and soft tissue (SSTI) N=111 (42%), 2) endocarditis N=70 (30%), 3) bone and joint N=26 (10%), 4) pyogenic spinal N=39 (15%), 5) isolated bacteremia N=9 (3%) 6) and acute viral hepatitis N=8 (3%). Of 338 admissions, 57% (N= 192) included infectious disease consultation; 50% resulted in discharge to another facility and 82% (excluding isolated SSTI) required multi-week intravenous antibiotics on discharge. By 15-months following the study period, 12% were deceased (N=28); 5 died during hospitalization.

Conclusion:

Our study describes the characteristics of patients hospitalized with IDU-related infection over a multi-year period in a region highly impacted by the opioid epidemic. High rates of hospital readmission, prolonged antibiotic therapy and out-of- hospital death were common in this young cohort.

Alison B. Rapoport, MD1,2, Danielle Fine, MD1, Jennifer Manne-Goehler, MD, DSc, MSc1, Shoshana J. Herzig, MD/MPH1,2 and Christopher F. Rowley, MD/MPH1,2,3, (1)Beth Israel Deaconess Medical Center, Boston, MA, (2)Harvard Medical School, Boston, MA, (3)Harvard School of Public Health, Boston, MA

Disclosures:

A. B. Rapoport, None

D. Fine, None

J. Manne-Goehler, None

S. J. Herzig, None

C. F. Rowley, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.